Patient
SITE006-0064
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE006 (GBR) (Dr. Rossi)
consented 2025-11-22
Adverse events
4
Serious AEs
2
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-10 (study day 109); relationship: not assessed
Grade 4 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-09-10 (study day 109); relationship: NOT RELATED; serious criteria: life-threatening
Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-08-26 (study day 94); relationship: not assessed; serious criteria: hospitalization
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-07-31 (study day 68); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.